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Cellular/Molecular
Mitochondrial Dysfunction Induces Sarm1-Dependent Cell
Death in Sensory Neurons
Daniel W. Summers,1,2 X Aaron DiAntonio,2,3 and Jeffrey Milbrandt1,3
1Department of Genetics, 2Department of Developmental Biology, and 3Hope Center for Neurological Disorders, Washington University School of Medicine,
St. Louis, Missouri 63110
Mitochondrial dysfunction is theunderlying causeofmanyneurological disorders, includingperipheral neuropathies.Mitochondria rely
on a proton gradient to generate ATP and interfering with electron transport chain function can lead to the deleterious accumulation of
reactive oxygen species (ROS). Notably, loss ofmitochondrial potential precedes cellular demise in several programmed cell destruction
pathways, including axons undergoing Wallerian degeneration. Here, we demonstrate that mitochondrial depolarization triggers axon
degeneration and cell death in primary mouse sensory neurons. These degenerative events are not blocked by inhibitors of canonical
programmed cell death pathways such as apoptosis, necroptosis, and parthanatos. Instead, the axodestructive factor Sarm1 is required
for this axon degeneration and cell death. In the absence of Sarm1, the mitochondrial poison CCCP still induces depolarization of
mitochondria, ATP depletion, calcium influx, and the accumulation of ROS, yet cell death and axon degeneration are blocked. The
survival of theseneuronsdespite theaccumulationofROS indicates that Sarm1actsdownstreamofROSgeneration. Indeed, lossof Sarm1
protects sensory neurons and their axons from prolonged exposure to ROS. Therefore, Sarm1 functions downstream of ROS to induce
neuronal cell death and axon degeneration during oxidative stress. These findings highlight the central role for Sarm1 in a novel form of
programmed cell destruction that we term sarmoptosis.
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Introduction
Mitochondria are biosynthetic factories responsible for the pro-
duction of ATP and other vital metabolites and serve as a nexus
for cell death pathways (Galluzzi et al., 2012). Neurons consume
tremendous amounts of energy and are particularly susceptible
to perturbations in mitochondrial function (Mora´n et al., 2012);
they also can project axons over long distances and must support
energetically demanding cellular processes from soma to synapse.
Defects in mitochondrial homeostasis can lead to axon degener-
ation, as highlighted by the debilitating peripheral neuropathy
caused by mutations in the mitochondrial fusion factor Mfn2
(Zu¨chner et al., 2004) and acquired neuropathies such as
diabetic-induced neuropathy (Vincent et al., 2011).
Injury-induced axon degeneration (or Wallerian degenera-
tion) is a localized form of programmed axon destruction that
occurs in response to axon trauma or disease. Axon degeneration
is an early pathological event in many neurological disorders
(Wang et al., 2012). After axonal injury, loss of mitochondrial
potential and mitochondrial swelling are observed in the severed
axon before axon fragmentation (Sievers et al., 2003; Park et al.,
2013). Pharmacological inhibitors that block opening of the mi-
tochondrial permeability transition pore extend axon survival in
transected sciatic nerve explants (Barrientos et al., 2011). There-
fore, as with other programmed cell death pathways, mitochon-
dria might be an important node in the regulation and execution
of Wallerian degeneration.
Recently, Sarm1 was identified as an essential component of
the Wallerian degeneration program (Osterloh et al., 2012;
Gerdts et al., 2013). Axons in Sarm1/-transected sciatic nerves
are preserved for several weeks after injury. In vitro, axons from
Sarm1/ neurons are similarly preserved after transection. The
sterile  motif (SAM) and toll-interacting receptor (TIR) do-
mains of Sarm1 are necessary to execute axon degeneration
(Gerdts et al., 2013), whereas a fragment containing only the
SAM-TIR domains is sufficient to induce cell death in sensory
neurons and immortalized cell lines (Gerdts et al., 2013; Panneer-
selvam et al., 2013). In addition, loss of Sarm1 blocks neuronal
cell death in models of oxygen-glucose deprivation and viral in-
fection (Kim et al., 2007; Mukherjee et al., 2013). Therefore,
Sarm1 likely plays a central role in neuronal cell death and axon
degeneration, yet its relationship to characterized programmed
cell death pathways is unknown.
We demonstrate here that mitochondrial dysfunction stimu-
lates a Sarm1-dependent cell destruction pathway in sensory
neurons. Notably, Sarm1-dependent cell death during mito-
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chondrial dysfunction is independent of caspases and is not
blocked by inhibitors of apoptosis, necroptosis, or parthanatos.
In response to mitochondrial dysfunction, reactive oxygen spe-
cies (ROS) levels accumulate in both WT and Sarm1-knock-out
neurons. Moreover, increasing ROS levels directly in sensory
neurons triggers axon degeneration and cell death in a Sarm1-
dependent manner, suggesting that ROS accumulation may be a
key upstream regulator of Sarm1 activation. These observations
collectively identify a novel Sarm1-dependent cell death pathway
in sensory neurons and reveal Sarm1 as a major regulator of both
local Wallerian degeneration and somatic cell death.
Materials and Methods
Reagents. The following compounds were from Sigma: carbonyl cyanide
3-chlorophenylhydrazone (CCCP), rotenone, 2-deoxyglucose (2-DG),
Ac-LLnL-CHO (ALLN), Necrostatin-1, hydrogen peroxide, paraquat,
and actinomycinD.Olaparibwas fromSelleckChemicals. Rucaparibwas
from Cayman Chemicals. Z-VAD-fmk was from Tocris Bioscience.
Ferrostatin-1 (Fer-1) was a gift from Scott Dixon (Stanford University).
Ethidium homodimer (EH) was from Biotum. Cells were incubated with
200 nM EH for 30 min before imaging. Rotenone was prepared fresh
immediately before use. Anti-4-hydroxy-2-nonenal (4-HNE) rabbit
polyclonal was from Alpha Diagnostic International. Anti-Opa1 mouse
monoclonal antibody was from BD Biosciences. Anti-tubulin mouse
monoclonal antibody was from Sigma. Anti Hsp60(D307) rabbit poly-
clonal antibody was from Cell Signaling Technology. Anti-Sarm1 mouse
monoclonal antibody was generated against aa492–501 from human
Sarm1 (Abmart) and characterized in our laboratory.
Culture ofmouse primary neurons.Primarymouse dorsal root ganglion
neuronswere isolated fromWTor Sarm1/ embryonic day 12.5mouse
embryos of either sex as described previously (Gerdts et al., 2013). Neu-
rons were maintained in neurobasal medium supplemented with
L-gluatmine (Invitrogen), 2% B27 (Invitrogen), 50 ng/ml nerve growth
factor (Harlan Laboratories), 1 M 5-fluoro-2-deoxyuridine (Sigma),
and 1 M uridine (Sigma). For cell death and axon degeneration assays,
200 cells were spotted per well in a 96-well plate coated with poly-D-
lysine and laminin. For biochemical analysis,20,000 cells were seeded
in 12-well plates coated with poly-D-lysine and laminin. Neurons were
infected at 2 d in vitro (DIV2) with lentiviruses generated as described in
the next paragraph. For higher-density cultures, the medium was re-
placed every 2 d. For lentiviral transduction experiments, neurons were
infected on late DIV1. All experiments were performed on DIV7.
Lentiviral transduction of neurons. Lentiviral plasmids expressing BclXl
and human Sarm1 constructs were used to generate lentiviral particles.
Details on these constructs can be found in Gerdts et al., 2013. Briefly,
lentiviral packaging plasmidswere cotransfectedwith lentiviral expressin
plasmids intoHEK293t cells (Sasaki et al., 2009). Lentiviral particles were
concentrated with Lenti-X concentrator (Clontech) and resuspended in
PBS. Concentrated lentivirus was stored at80°C. Equivalent transduc-
tion efficiency of Sarm1 constructs was assessed by monitoring Venus
expression.
Analysis of axon degeneration and cell death. Images were collectedwith
an Operetta High Content Image System (PerkinElmer) as described
previously (Gerdts et al., 2011). Briefly, bright-field images (20 objec-
tive) were collected from fields containing only axons. At least six fields
per condition in each independent experiment were analyzed using an
in-house ImageJ macro to calculate axon degeneration (Sasaki et al.,
2009). In this macro, binarized images were assigned a degeneration
index score derived from the ratio of fragmented axon area (defined by
circularity of an axon particle) to total axon area in a given field. For cell
death, neurons were incubated with ethidium homodimer for 30 min
before imaging to label dead soma. At least four fields were collected as
described in this paragraph. Percentage cell death was measured as the
ratio of soma that stained positive with ethidium homodimer to total
soma at the indicated time point. At least 100 cells were counted per
condition in each experiment. For all analyses, at least three independent
experiments were performed. Statistical significance was determined by
paired t test and is indicated in the figures.
Analysis of mitochondrial dynamics. To measure mitochondrial shape,
neurons were infected with lentivirus expressing mitoDSred and fixed
cells were imaged with a Nikon confocal microscope (60 objective).
Confocal stacks were obtained and z-projected and mitochondrial shape
was analyzedwithCellProfiler software. Briefly, individualmitochondria
from distal axons were identified and the ratio of major to minor axis
from each mitochondrion was used to calculate “roundness.” At least
eight independent images were used in the analysis and800 mitochon-
dria were measured per condition. For mitochondrial motility,
mitoDSred-labeled mitochondria were monitored from distal axons us-
ing the Operetta High Content System (PerkinElmer). Individual distal
axons were imaged with a40 objective. Frames were collected every
3 s for 2.5min. Kymographswere generatedwith ImageJ software and the
percentage of motile mitochondria was quantified from at least three
independent experiments (quantifying at least two movies per condition
and 10 individual axon segments per experiment).
Measurement of ATP levels. ATP was extracted from neurons using the
perchloric acid/sodium carbonate method and analyzed by high-
performance liquid chromatography. ATP concentrations were deter-
mined by comparison with standard curves (Viader et al., 2013).
ROS indicator dye. Dihydroethidium (DHE) from Life Technologies
was freshly prepared immediately before each experiment. Neurons
treated as indicated in the text were incubated with DHE at a final con-
centration of 1 M for 15 min then soma were imaged with the Operetta
High Content System (PerkinElmer). Images were collectively analyzed
for DHE intensity using ImageJ software.
Fluo-4AM imaging. Fluo4AM from Life Technologies was prepared
fresh and added to neurons at a final concentration of 2.5 M for 30 min
before the experiment. After treatment, neuronal soma and axons were
imaged with the Operetta High Content System. For axotomy experi-
ments, cells were preloaded with Fluo-4AM and axons severed with a
razor blade. Axon segments distal to the cut site were imaged at the
indicated time points. Images were collectively analyzed for Fluo-4AM
intensity with CellProfiler software.
L-Lactate measurements. L-Lactate was measured from media using an
L-lactate determination kit (Eton Bioscience). Twenty-four hours before
the experiment, media on neurons were replaced with phenol-red free
media supplemented with the components described for the culture of
primary neurons. Cells were treated as described, media were collected,
and L-lactate was analyzed following the manufacturer’s recommenda-
tions and standards.
Results
Loss of Sarm1 protects neurons from
mitochondrial dysfunction
Mitochondrial depolarization is an early molecular event in sev-
ered axonal segments that precedes axon blebbing and fragmen-
tation (Sievers et al., 2003; Park et al., 2013). Furthermore,
diverse programmed cell death pathways trigger mitochondrial
depolarization before complete loss of cell viability (Andrabi et
al., 2008; Galluzzi et al., 2009). We therefore investigated whether
loss of mitochondrial potential in sensory neurons is sufficient to
induce axon degeneration and cell death. The protonophore
CCCP rapidly and directly stimulates mitochondrial depolariza-
tion and is widely used to study how changes in mitochondrial
potential affect cellular viability (Ly et al., 2003). Prolonged ex-
posure to CCCP (50M) causes axon degeneration and neuronal
cell death (Fig. 1A,B). A temporal analysis reveals that axon frag-
mentation precedes cell death by up to 12 h and becomes most
apparent 24 h after CCCP addition. These results suggest that
mitochondrial depolarization induced by CCCP treatment stim-
ulates a cellular destruction pathway in sensory neurons that re-
sembles Wallerian degeneration.
The suppression of axon degeneration in Sarm1-deficient
neurons in response to other types of damage and the mitochon-
drial location of Sarm1 encouraged us to investigate its role in
mitochondrial-depolarization-induced neuron destruction. We
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found that Sarm1/ neurons are highly resistant to CCCP-
induced axon degeneration and cell death for24 h (Fig. 1C–F).
CCCP triggers loss of mitochondrial potential and thus impairs
oxidative phosphorylation. We demonstrated previously that ex-
posure to the ETC complex I inhibitor rotenone induces axon
degeneration and cell death in neurons (Press and Milbrandt,
2008). We therefore tested whether inhibiting ETC function with
rotenone also stimulates Sarm1-dependent cell death and axonal
Figure 1. Mitochondrial dysfunction stimulates Sarm1-dependent axon degeneration and cell death.A, Bright-field images from a field of neuronal distal axons treatedwith 50M CCCP for the
indicated time. Right, Quantification of axon degeneration after CCCP treatment (n 3).B, Bright-field images from a field of neuronal soma treatedwith 50M CCCP during the same time course
experiment as in A. Neuronal soma are incubatedwith 200 nM ethidium homodimer (red). Arrowheads indicate examples of membrane protrusions from dying soma. Quantification of cell death is
shown on the right (n 3). C, D, Quantification of axon degeneration from WT and Sarm1/ neurons treated with 50 M CCCP for 24 h or treated with 25 M rotenone for 36 h (n 3).
Representative bright-field images of distal axons. E, F, Quantification of cell death from WT and Sarm1/ neurons treated as in C (n 3). Shown are representative bright-field images of
neuronal soma incubated with ethidium homodimer (red). Error bars represent SEM. Scale bars, 25m. *p 0.05; **p 0.01.
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degeneration. We found that the axons and soma of Sarm1/
neurons treated with rotenone remain intact for 36 h (Fig.
1C–F). Together, these data indicate thatmitochondrial dysfunc-
tion induces a Sarm1-dependent cell destruction pathway in sen-
sory neurons.
Cytosolic Sarm1 is sufficient to drive CCCP-induced
cell death
Sarm1 possesses an N-terminal mitochondrial targeting se-
quence (MTS) that is required for association with the outer
mitochondrial membrane (Panneerselvam et al., 2012; Fig. 2A).
The importance of mitochondrial localization is unknown be-
cause Sarm1 protein lacking this domain is cytosolic and fully
capable of activating the axotomy-induced axon degeneration
pathway (Gerdts et al., 2013). Although several studies indicate
that Sarm1 mitochondrial localization could be important for
cell death (Kim et al., 2007; Mukherjee et al., 2013; Panneersel-
vam et al., 2013), a requirement for Sarm1 mitochondrial associ-
ation in promoting cell death has not been tested. We
investigated whether a Sarm1 mutant lacking the MTS,
Sarm1(	MTS), which localizes to the cytosol, could promote
axon degeneration and neuron cell death when expressed in
CCCP-treated Sarm1/ neurons (Fig. 2B,C). Sarm1(	MTS)
mediated both axon degeneration and cell death in CCCP-
treated Sarm1/ neurons to a similar extent as WT Sarm1. Our
previous study of Sarm1 function demonstrated that both the
SAM and TIR domains are required for degeneration of tran-
sected axons. We therefore tested the previously described Sarm1
mutants that disrupt each of these critical domains by expressing
them in CCCP-treated Sarm1/ neurons. We found that, con-
sistent with our previous study of axon transection, the SAM and
TIR domain mutants abolished the ability of Sarm1 to mediate
CCCP-induced axon degeneration and cell death (Fig. 2B,C).
These observations collectively demonstrate that Sarm1 uses the
same functional domains to execute cell destruction after mito-
chondrial dysfunction as it does for injury-induced axon
degeneration.
Mitochondria in Sarm1/ neurons undergo
depolarization-induced changes
One potential explanation for the lack of CCCP-induced cell de-
struction in Sarm1-deficient neurons is that the mitochondria in
these cells are altered in such a way that they do not respond
normally to mitochondrial depolarization. Because depolariza-
tion stimulates several well documented changes in mitochon-
drial dynamics, we investigated these responses in WT and
Sarm1-deficient neurons treated with CCCP. Mitochondrial po-
tential in CCCP-treated neurons was examined using the dye
tetramethylrhodamine methyl ester (TMRM). We found that
CCCP stimulates a rapid loss of the TMRM signal from soma and
axons in both WT and Sarm1/ neurons, demonstrating that
mitochondria are depolarized by CCCP in the absence of Sarm1
(Fig. 3A). One of the earliest markers of mitochondrial depolar-
ization is the voltage-dependent proteolysis of the mitochondrial
inner membrane factor Opa1 (Duvezin-Caubet et al., 2006; Ishi-
hara et al., 2006). CCCP treatment induced completeOpa1 cleav-
age in both WT and Sarm1/ neurons, confirming that CCCP
induces mitochondrial depolarization in Sarm1-deficient neu-
rons (Fig. 3B).
To explore other potential mitochondrial phenotypes that
could account for the protection of Sarm1/ neurons from
CCCP, we assessed mitochondrial number, shape, and transport.
Quantification of axonal mitochondria revealed no difference in
the number of mitochondria in Sarm1-deficient axons either in
the presence or absence of CCCP (Fig. 3C). Therefore, protection
from CCCP-induced destruction in Sarm1-deficient neurons is
not due to an elevated number of mitochondria. The equilibrium
between mitochondrial fusion and fission is enormously impor-
tant for the health of the cell, and abnormalities in these processes
contribute to a number of diseases, including neurologic disor-
ders (Youle and van der Bliek, 2012). Healthy mitochondria are
elongated, whereas depolarized mitochondria take on a more
rounded shape. This is likely due to a reduction in mitochondrial
fusion and increase in mitochondrial fission that occur in re-
sponse to mitochondrial depolarization (Duvezin-Caubet et al.,
2006). Mitochondrial shape can thus be used as a basic measure
of fusion/fission equilibrium and of mitochondrial health in gen-
eral. A population analysis of mitochondria in WT versus
Sarm1/ axons revealed no difference in mitochondrial shape
at steady state (Fig. 3D). CCCP treatment converted the mito-
chondrial population of both WT and Sarm1/ neurons to a
rounder shape (Fig 3D,E), indicating that the fusion/fission dy-
namics change normally in stressed Sarm1 mutant neurons.
Finally, mitochondrial motility is an important indicator of
axonal health, and decreased motility can lead to axon degener-
ation (Baloh, 2008; Schwarz, 2013). Indeed, mitochondrial dys-
function can activate a signaling cascade that results in reduced
Figure 2. Analysis of structural features required for Sarm1 action in CCCP-induced degen-
eration and death. A, Domain structure of Sarm1 with location of alanine replacement muta-
tions highlighted. Sarm1/ neurons were transduced with lentiviruses expressing the
indicated construct. At DIV7, neurons were treated with 50M CCCP and then axon degenera-
tion (B) and cell death (C) were measured (n  3). Error bars represent SEM. Statistically
significant differences are noted in the figure. *p 0.05; **p 0.01.
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mitochondrial motility (Wang et al., 2011). We investigated mi-
tochondrial motility in WT and Sarm1/ neurons and did not
find a difference in basalmitochondrialmotility as assessed by the
percentage of motile mitochondria (Fig. 3F,G) and average mi-
tochondrial velocity (data not shown). Because mitochondrial
depolarization triggers a block in the movement of mitochondria
within the axon (Miller and Sheetz, 2004), we investigated
whether this was also the case in Sarm1-deficient axons. We found
that CCCP treatment caused a complete block in mitochondrial
movement in bothWTandSarm1/neurons, demonstrating that
axonal mitochondrial movement is independent of Sarm1. To-
gether, these observations demonstrate that mitochondria in
Sarm1/ and WT neurons respond very similarly to depolariza-
tion, indicating that Sarm1 must act downstream of mitochondrial
dysfunction in driving axon degeneration and cell death.
Sarm1/ neurons rely on glycolysis to survive prolonged
mitochondrial depolarization
Sarm1 could block cell death by maintaining ATP levels in the
face of mitochondrial dysfunction either through alterations in
mitochondrial function itself or by stimulating ATP production
through glycolysis. CCCP treatment abolishes the H
 gradient
Figure 3. Mitochondrial dynamics of depolarizedmitochondria inWT and Sarm1/neurons.A,WT and Sarm1/neuronswere loadedwith TMRM to label polarizedmitochondria. Neurons
were treatedwith DMSOor 50M CCCP and bright-field and TMRM fluorescent imageswere acquired. Scale bar, 25M.B, Lysates ofWT and Sarm1/ neurons treatedwith DMSOor 50M CCCP
for 4hwereanalyzedbyWesternblottingwith the indicatedantibodies.C, Quantificationofmitochondria fromWTandSarm1/neuronstreatedwithDMSOor50MCCCPfor4h(n3).D,Population
analysis ofmitochondrial shape inWTand Sarm1/neurons. The ratio ofmajor tominor axis of themitochondriawas used to calculate “roundness” and is displayed as a cumulative frequency distribution.
Mitochondriawere alsomeasured inneurons treatedwith50MCCCP for 4h.E, Images of axonalmitochondria fromWTandSarm1/neurons treatedwith50MCCCPorDMSO for 4h. Scale bar, 12M.
F, Kymographs of mitochondrial movement in WT and Sarm1/ neurons treated with DMSO or 50M CCCP for 4 h.G, Quantification of percentage motile mitochondria from WT or Sarm1/ neurons
treatedwith 50MCCCP or DMSO for 4 h (n 3). Statistical analysis did not reveal any differences betweenWTand Sarm1/neurons. Error bars represent SEM.
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across the inner mitochondrial membrane such that ATP syn-
thase can no longer generate ATP from oxidative phosphoryla-
tion. We examined ATP levels at various times after CCCP
addition and found that ATP levels drop precipitously to15%
of control levels within 4–6 h in both WT and Sarm1-deficient
neurons (Fig. 4A). ATP levels reach their nadir slightly before we
observed axon fragmentation but well before cell death (see Fig.
1B). Importantly, the kinetics of the ATP decline were essentially
equivalent in CCCP-treated WT and Sarm1/ neurons. There-
fore, WT and Sarm1/ neurons primarily rely on oxidative
phosphorylation to generate ATP, and interfering with ETC
function causes a major drop in cellular ATP levels regardless of
Sarm1.
We hypothesized that neurons incapable of oxidative phos-
phorylation would attempt to fulfill their energy requirements
by shifting their metabolism toward glycolysis. To test this
idea, we measured lactate levels in the medium of WT and
Sarm1 mutant neurons grown in the absence or presence of
CCCP. We found that lactate levels increased equivalently in
neurons of both genotypes when they were grown in CCCP
(Fig. 4B). We next investigated how WT and Sarm1 mutant
neurons responded to treatment with 2-DG, an inhibitor of
glycolysis (Wick et al., 1957). Although treatment with 2-DG
alone had minimal effects on axon degeneration or neuronal
survival, cotreatment with CCCP and 2-DG accelerated axon
degeneration and cell death in both WT and Sarm1 mutant
neurons (Fig. 4C,D). Therefore, neuron preservation in Sarm1
mutant neurons after CCCP treatment is not due to an altered
ability to produce ATP by either glycolysis or oxidative
phosphorylation.
Figure 4. Sarm1/ neurons use glycolysis to survive prolonged mitochondrial depolarization. A, Measurement of ATP levels as a percentage of control (DMSO) from WT and Sarm1/
neurons during CCCP treatment. B, L-Lactate levels in media were measured from WT and Sarm1/ neurons treated with DMSO or 50M CCCP (n 4). Data are represented as a percentage of
control. C, Axon degeneration in distal axons from WT and Sarm1/ treated with DMSO, 50M CCCP, 5 mM 2-DG, or 50M CCCP
 5 mM 2-DG (n 3). Below are representative images from
neurons treated as described.D, Cell death inWT and Sarm1/ neurons treated as in C (n 3). Below are representative images of neuronal soma stainedwith ethidiumhomodimer (red). Axon
degeneration and cell death were quantified 24 h after treatment. Scale bars, 25m. Statistically significant differences are noted in the figure. *p 0.05; **p 0.01.
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CCCP-induced cell death does not rely on other known
programmed cell death factors
The experiments described thus far identify a Sarm1-dependent
cell destruction pathway in neurons that is provoked by CCCP-
induced mitochondrial dysfunction. We next explored whether
this Sarm1-dependent pathway is similar or identical to a previ-
ously characterized programmed cell death pathway. Because
Sarm1 is implicated in T-cell apoptotic death (Panneerselvam et
al., 2013), we first tested whether CCCP-induced axon degener-
ation and cell death rely on key steps in the apoptotic pathway.
We treated WT neurons with the pan-caspase inhibitor Z-VAD-
fmk or overexpressed the anti-apoptotic factor BclXl to block
cytochrome c release. We found that, whereas both conditions
suppressed apoptotic cell death triggered by NGF deprivation
(Fig. 5A,B), neither affected the axon degeneration or cell death
caused byCCCP treatment. Apoptosis also requires transcription
(Chen et al., 2012) and CCCP-induced cell death occurs after
24–36 h of treatment, so we were curious whether transcription
was required for this Sarm1-dependent cell-destructive process.
We treated neurons with the transcriptional inhibitor actinomy-
cin D before CCCP administration, but this treatment did not
suppress CCCP-induced death or axon degeneration (Fig. 5C,D).
Therefore, the Sarm1-dependent cell death triggered by CCCP is
nonapoptotic. These data are consistent with our previous find-
ings that neither caspase inhibitors nor expression of BclXl block
either axotomy-induced axon degeneration or cell death induced
by expression of the Sarm1 SAM-TIR domain (Vohra et al., 2010;
Gerdts et al., 2013).
Several other forms of programmed cell death have been char-
acterized recently, including necroptosis, parathantos, and fer-
roptosis (Andrabi et al., 2008; Dixon et al., 2012; Wu et al., 2012).
Well characterized pharmacological inhibitors to the critical
steps of each of these programmed cell death pathways were
tested in neurons treated with CCCP. None of these inhibitors,
whichwere used at concentrations based on previously published
studies (Weston et al., 2010; Ali et al., 2011; Dixon et al., 2012; Re
et al., 2014), had any effect on CCCP-induced axon degeneration
or cell death (Fig. 5E,F). Furthermore, shRNAs to Parp1 and
Ripk3 also had no effect on axon degeneration or cell death in this
paradigm (data not shown). Therefore, Sarm1mediates a distinct
form of cell death. As an independent test of this hypothesis, we
activated Sarm1 signaling directly. We demonstrated previously
that the inducible expression of the C terminus of Sarm1, which
contains the SAM-TIR domains but not the auto-inhibitory
N-terminal domain, is sufficient to trigger nonapoptotic cell
death and axon degeneration in neurons (Gerdts et al., 2013).
Here, we tested pharmacological inhibitors of these additional cell
death pathways using Sarm1 SAM-TIR expression. As with CCCP
treatment, these inhibitorshadnoeffectonaxondegenerationorcell
death triggered by SAM-TIR (Fig. 5G,H). Altogether, these results
indicate that the Sarm1-dependent cell-destructive process,whether
triggered by CCCP or via the direct activation of Sarm1 signaling, is
a novel pathway that does not use key steps of previously character-
ized cell death pathways.
Sarm1 acts downstream of Ca2 influx during
mitochondrial depolarization
Disturbances in mitochondrial function can interfere with cal-
cium homeostasis and cause a dangerous accumulation of cal-
cium ions in the cytosol (Brookes et al., 2004), so we tested
whether calcium is required for Sarm1-dependent neuronal de-
mise during mitochondrial dysfunction. Indeed, we found that
EGTA potently suppresses both axon degeneration and cell death
uponCCCP treatment (Fig. 6A,B), indicating that calcium influx
is an important step in the cell destruction pathway triggered
during mitochondrial dysfunction. This is in contrast to our pre-
vious findings that EGTA does not block neuronal cell death in
response to expression of the Sarm1 SAM-TIR domain, in which
the regulatory N-terminal half of Sarm1 is deleted (Gerdts et al.,
2013). This finding that endogenous Sarm1 requires calcium, but
the constitutively active Sarm1 truncation mutant does not, sug-
gests that calcium may activate full-length Sarm1. We tested
whether this activation may involve calpains, calcium-activated
proteases that function in a variety of neurodegenerative disor-
ders and promote Wallerian degeneration of injured axonal seg-
ments (George et al., 1995; Yang et al., 2013). However, addition
of the calpain I inhibitor ALLN has no effect on CCCP-induced
axon degeneration or cell death (Fig. 6A,B), so other calcium-
dependent processes must be promoting these degenerative
events.
Because calcium influx is necessary for CCCP-induced axon
degeneration and neuronal death, we tested whether loss of
Sarm1 could block this critical step. We used the Ca2
 indicator
dye Fluo4AM and fluorescence microscopy to monitor intracel-
lular Ca2
 levels after CCCP treatment. We found that CCCP
stimulates a robust increase in Ca2
 within the axons and soma
(Fig. 6C,D). Importantly, there is an equivalent increase in axonal
and somal Ca2
 in bothWT and Sarm1mutant neurons.We and
others demonstrated previously that Sarm1 is required for degen-
eration of severed axonal segments (Osterloh et al., 2012; Gerdts
et al., 2013). Consistentwith our observations, calcium levels rose
in transected axons within 30 min of injury in both WT and
Sarm1/ axons (Fig. 6E). Therefore, calcium influx is necessary
for CCCP-induced cell death; however, this influx is not depen-
dent on Sarm1, consistent with the model that Sarm1 acts down-
stream of calcium entry.
Sarm1 deficiency protects neurons from ROS accumulation
Mitochondria generate low levels of ROS at steady state; however,
interfering with ETC function stimulates high levels of ROS pro-
duction (Halliwell, 2006; Federico et al., 2012). Therefore, the
absence of Sarm1 could suppress axon degeneration and cell
death induced by mitochondrial inhibitors by blocking ROS ac-
cumulation. We examined ROS levels in WT and Sarm1/ neu-
rons after exposure to CCCP using the cell-permeable ROS
indicator dye DHE and fluorescent microscopy. We found that
CCCP triggered an equivalent increase in DHE intensity in both
WT and Sarm1 mutant neurons (Fig. 7A,B), indicating that ROS
accumulates similarly in Sarm1 mutant and WT neurons treated
with CCCP.
Although loss of Sarm1 did not affect ROS accumulation after
CCCP treatment, we reasoned that it may influence the damage
caused by high ROS levels. To test this possibility, we examined
the level of lipid peroxidation in these cells by measuring the
levels of 4-HNE, a major product of lipid oxidative damage. WT
and Sarm1 mutant neurons treated with CCCP were stained with
antibodies to 4-HNE and examined by fluorescence microscopy.
CCCP treatment increases 4-HNE levels equivalently in Sarm1
and WT neurons, indicating that loss of Sarm1 does not prevent
oxidative damage induced by elevated levels of ROS (Fig. 7C).
These observations indicate that Sarm1/ neurons tolerate
high levels of ROS, but do not fully escape oxidative damage.
Further, they imply that Sarm1 is acting downstream of ROS
generation to drive axon destruction and death. To test this hy-
pothesis, we treated WT and Sarm1/ neurons with hydrogen
peroxide to induce ROS accumulation directly and invoke oxida-
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Figure 5. Analysis of programmed cell death pathways in CCCP-induced axon degeneration and cell death. WT neurons were transduced with lentivirus expressing BclxL or pretreated with the
pan-caspase inhibitor Z-VAD-fmk (10g/ml). Neurons were then treated with 50M CCCP or deprived of NGF and analyzed 24 h later for axon degeneration (A) and cell death (B). In C andD, WT
neurons were treatedwith actinomycin D (1g/ml) andwith CCCP as described for A andB. Axon degeneration and cell death weremeasured 24 h later. In E and F, WT neurons were treatedwith
indicated compound: ferrostatin 1 (Fer-1; 1M), necrostatin 1 (Nec-1; 5M), olaparib (1M), or rucaparib (0.5M). Neurons were then treated with 50M CCCP and analyzed 24 h later for axon
degeneration and cell death (n 3).G,H, Neurons were infectedwith DIO SAM-TIR lentivirus that expresses Sarm1 SAM-TIR domain in a Cre-dependent fashion. Two days later, the neurons were
infected with Cre-expressing while in the presence of the indicated inhibitors. Thirty-six hours later, cells were assessed for axon degeneration (G) and cell death (H ) (n 3). Error bars represent
SEM. Statistically significant differences are noted in the figure. **p 0.01; ***p 0.001.
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tive damage. Exposure to hydrogen peroxide causes axon degen-
eration and cell death in WT neurons in a dose-dependent
manner (Press and Milbrandt, 2008; Fig. 8A,B). In contrast,
Sarm1/ neuronal soma and axons are profoundly resistant to
hydrogen peroxide-induced degeneration. Interestingly, at high
doses of hydrogen peroxide, Sarm1 neurons began to die, but
their axons remained fully intact, suggesting that Sarm1 is partic-
ularly important for mediating axonal destruction in response to
ROS. We confirmed that hydrogen peroxide treatment generates
increased ROS in both WT and Sarm1/ neurons using DHE
dye and increased lipid peroxidation using 4-HNE staining (data
not shown).
Figure 6. Calcium influx during mitochondrial dysfunction. Neurons were treated with 50M CCCP alone or in presence of ALLN (25M) or EGTA (2.5 mM). A, B, Axon degeneration (A) or cell
death (B) weremeasured 24 h after treatment (axon degeneration: *p 0.001; cell death: *p 0.01; two-sample t test). C, Images ofWT and Sarm1/ neuronal somawere preincubatedwith
the calcium indicator dye Fluo-4AM. Neuronswere treatedwith DMSO or 50M CCCP for 8 h. Quantification of Fluo-4AM intensity of the soma is shown on the right (n 3).D, Images of Fluo-4AM
fluorescence in distal axons from WT and Sarm1/ neurons (n 3) treated as in C. E, Axons from WT and Sarm1/ DRGs were transected and Fluo4AM intensity measured in distal axons at
the indicated times after axotomy (n 4). Quantification of the ratio of Fluo-4AM intensity to total axon area (per 500 pixels) is shownon the right. Fluo4-AM intensitywas not statistically different
between WT and Sarm1/ neurons in any of the experiments. Scale bars, 25m.
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As an alternative method for generating ROS, neurons were
treated with the herbicide paraquat. Paraquat is enzymatically re-
duced inside the cell to a reactive intermediate that increases ROSby
essentially converting oxygen into ROS (Castello et al., 2007). Para-
quat exposure, like rotenone, is used as a pharmacological model of
Parkinson’s disease and disorders linked to oxidative stress. Consis-
tent with our results with hydrogen peroxide, Sarm1 mutant neu-
rons show robust resistance to paraquat exposure (Fig. 8C,D).
Collectively, these observations demonstrate an important role for
Sarm1 in mediating the damage initiated by oxidative stress.
Discussion
Mitochondrial dysfunction is an underlying cause of many hu-
man diseases (Rugarli and Langer, 2012). Mitochondria are hubs
for ATP synthesis, Ca2
 buffering, and a reservoir for death sig-
naling molecules, including cytochrome c. In addition, loss of
mitochondrial potential occurs in many cellular destruction path-
ways, including apoptosis, necroptosis, and Wallerian degeneration
(Viraget al., 1998; Iijima,2006;Galluzzi et al., 2009). In this study,we
demonstrate that mitochondrial depolarization stimulates a cell de-
struction pathway in sensory neurons that is dependent on the TIR
adaptor protein Sarm1. Further investigation revealed that Sarm1-
dependent cell death in neurons treated with CCCP to depolarize
mitochondria is mechanistically distinct from other forms of cell
death, including apoptosis, necroptosis, parthanatos, and ferropto-
sis. This Sarm1-dependent cellular destruction process, which we
term sarmoptosis, is an important new addition to the molecular
basis of programmed cell destruction.
Sarm1-dependent cell destruction
Sarm1 has been implicated previously in other models of neuro-
nal cell death, including viral infection in vivo and oxygen–glu-
cose deprivation in vitro (Kim et al., 2007;Mukherjee et al., 2013).
Both of these studies suggest that Sarm1 is required for neuronal
apoptosis. Kim et al. (2007) demonstrated that hippocampal slice
cultures from Sarm1/ mice are resistant to cell death induced
by oxygen glucose deprivation, a prominent ex vivo model of
ischemic injury that is associated with elevated Ca2
 and ROS
levels (Tuttolomondo et al., 2009). Sarm1 is also required for
neuronal death in a Bunyavirus infection model (Mukherjee et
al., 2013). In this system, loss of Sarm1 leads to a reduction in
ROS levels in the virus-infected neurons. It is clear from these
studies that Sarm1 is an important component of a neuronal
death pathway, although which Sarm1 domains are involved in
this function were not examined.
Sarm1 has also been associated with cell death in non-
neuronal cells. Mitochondrial localization of Sarm1 was found to
be crucial for its proapoptotic activity in T cells (Panneerselvam
et al., 2012; Panneerselvam et al., 2013), whereas we found that
Sarm1 tethering to the outer mitochondrial membrane is not
required to drive neuronal cell death after mitochondrial depo-
larization. In T cells, caspase activation and apoptosis were in-
duced by overexpression of WT Sarm1 or Sarm1 fragments
containing the SAM-TIR domains Panneerselvam et al., 2012;
Gerdts et al., 2013). In contrast, full-length Sarm1 had no effect
on neuronal integrity. Exogenous expression of a Sarm1 frag-
ment including only the SAM-TIR domains induces axon degen-
eration and neuronal cell death, but this proceeds through a
caspase-independent pathway (Gerdts et al., 2013). In the present
study, we show that neuronal cell death and axon degeneration
provoked by mitochondrial impairment are dependent on
Sarm1, but are independent of transcription and caspase activa-
tion, which are both features of apoptosis. Therefore, the Sarm1-
dependent cell death pathway that we describe in neurons is
distinct from the proapoptotic Sarm1 activity observed in T cells.
Nonapoptotic programmed death pathways drive cellular
loss in many disorders (Andrabi et al., 2008; Galluzzi et al.,
2011). For example, pharmacological inhibitors of necroptosis
and parthanotos reduce cellular demise after ischemic injury in
the brain (Abdelkarim et al., 2001; Northington et al., 2011). In
our study, whereas Sarm1 is clearly required for CCCP-induced
neuronal cell death, inhibitors of nonapoptotic programmed cell
death pathways, including RIP1 kinase (necroptosis), PARP1
(parthanatos), and the Xc-Cys/Glu antiporter system (ferropto-
sis) had no effect on CCCP-mediated cell destruction. Further,
inhibiting these pathways does not block cell death induced by
the constitutively toxic SAM-TIR C-terminal domain of Sarm1,
Figure 7. Mitochondrial dysfunction induces ROS generation in WT and Sarm1/ neu-
rons. A, WT and Sarm1/ neurons were treated with DMSO or 50M CCCP for 8 h. Neurons
were loaded with the ROS indicator dye DHE and images of DHE fluorescence were acquired.
Bright-field images of soma were also acquired and merged images are shown at right. Scale
bar, 25m.B, Quantification of DHE fluorescence in neurons treated as inA (n 3). Statistical
analysis indicates no significant difference in DHE intensity after CCCP treatment between WT
and Sarm1/ DRGs. C, Immunofluorescence images of WT and Sarm1/ neurons treated
as inA and stained for HNE, a product of lipid peroxidation. Note the equivalent staining in both
WT and Sarm1/ neurons. Scale bar, 20m. Error bars represent SEM.
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indicating that Sarm1 activation drives a novel form of cell death
in neurons.
Interestingly, the Sarm1 ortholog TIR-1 has been linked to
nonapoptotic cell death in Caenorhabditis elegans (Blum et al.,
2012), suggesting that the Sarm1 role in cell death is quite ancient.
In light of the growing prominence and breadth of Sarm1 action
in cellular demise, we propose that sarmoptosis represents an
unrecognized mode of programmed cellular destruction.
Sarm1-deficient neurons use glycolysis to survive prolonged
mitochondrial dysfunction
Neurons rely predominantly on oxidative phosphorylation to
fulfill extensive metabolic needs (Kann and Kova´cs, 2007), yet
sensory neurons lacking Sarm1 survive prolonged mitochondrial
depolarization. Analysis of mitochondrial dynamics from
Sarm1/ neurons indicates that they respond normally to de-
polarization (i.e., enhanced fission and loss of motility). In addi-
tion, mitochondrial depolarization causes a substantial loss of
ATP in neurons lacking Sarm1. Loss of Sarm1 does not protect
mitochondria from depolarization-induced damage, so these
neurons must survive in the absence of oxidative phosphoryla-
tion, relying on glycolysis for ATP production. This is borne out
of the observation that treatment with the glycolytic inhibitor
2-DG suppresses the protection from mitochondrial dysfunction
afforded by Sarm1 deficiency. Although oxidative phosphoryla-
tion is the principal means of neuronal ATP generation, other
studies have shown that enhancing flux through the glycolytic
pathway is protective in ischemic injury in the retina and rote-
none exposure in retinal cultures (Casson et al., 2004; Ebneter et
al., 2011; Han et al., 2013). Neuronal death due to Bunyavirus
infection is Sarm1 dependent and is associated with alterations in
mitochondria morphology and function (Mukherjee et al.,
2013). It is interesting that these mitochondrial abnormalities do
not occur in Sarm1-deficient mice (Mukherjee et al., 2013);
therefore, neurons possess metabolic flexibility that allow them
to survive mitochondrial failure when prodeath factors such as
Sarm1 are inactivated. Interestingly, Sarm1 interacts with the mi-
tochondrial stress kinase Pink1 (Murata et al., 2013), yet whether
Sarm1 functions with Pink1 or other factors to sense changes in
mitochondrial health directly remains to be determined. It ap-
pears that Sarm1 may promote cell destruction via disruption of
energy utilization pathways, perhaps by influencing neuronal en-
ergetic flexibility through altered usage of glycolytic versus mito-
chondrial energy production.
Oxidative stress and Sarm1 activation
Oxygen-glucose deprivation induces Sarm1-dependent cell
death (Kim et al., 2007); however, numerous physiological
Figure 8. Sarm1/ neurons are resistant to oxidative stress. A, WT and Sarm1/ neurons were treated with the indicated doses of hydrogen peroxide (H2O2). Axon degeneration was
measured24hafter treatment (n3).B, Neuronswere treated as inA and cell deathwasmeasured24hafter treatment (n3). Beloware representative images of distal axons and soma (treated
with EH to label dead cells). C, D, Quantification of axon degeneration (C) and cell death (D) in neurons treated with 25M paraquat for 24 h (n 3). Error bars represent SEM. Scale bars, 25m.
Statistically significant differences are noted in the figure. *p 0.05; **p 0.01.
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changes occur in response to this stress (including mitochondrial
dysfunction) and little is known regarding what molecular events
might trigger Sarm1 activation. Here, we demonstrate that cal-
cium influx is necessary for CCCP-induced cell death and likely
functions upstream of Sarm1 activation. First, we show that both
CCCP and axotomy lead to rapid Sarm1-independent calcium
influx. Second, blocking this calcium influx with EGTA protects
neurons from cell death and axon degeneration after CCCP treat-
ment. Therefore, calcium influx is necessary for Sarm1-
dependent death in response to CCCP. This is in striking contrast
to our previous finding that EGTA does not block DRG cell death
induced by expression of the Sarm1 SAM-TIR fragment, inwhich
the auto-inhibitory N-terminal domain is deleted (Gerdts et al.,
2013). These data lead to a model in which injury-induced cal-
cium influx activates Sarm1 to engage the downstream death/
degeneration pathway.
Although this model posits that calcium is upstream of Sarm1
activation, we do not suggest that this effect is direct; for example,
Sarm1 may be activated by the ROS accumulation that occurs in
response to excessive calcium influx (Nakamura and Lipton,
2010).Mitochondrial failure causes ROS accumulation and dam-
age to cellular proteins and lipids (Gandhi and Abramov, 2012).
The accumulation of ROS and consequent oxidative damage to
cellular lipids and proteins is thought to trigger neuronal damage
directly (Federico et al., 2012). We demonstrate that whereas loss
of Sarm1 blocks mitochondrial depolarization-induced cell de-
struction, ROS accumulation and oxidative damage (e.g., lipid
peroxidation) proceed in the absence of Sarm1. How Sarm1 loss
protects neurons in the presence of high levels of ROS and the
increased ROS-mediated damage after CCCP treatment is uncer-
tain. However, ROS-dependent cell destruction must require
Sarm1, because increasing ROS levels directly in neurons with
hydrogen peroxide or paraquat generates oxidative damage that
kills WT neuron, whereas Sarm1 mutant neurons remain intact.
Therefore, ROS could activate Sarm1 directly either by acting
directly on the auto-inhibitory N-terminal domain of Sarm1 to
unleash the destructive capabilities of the C-terminal SAM-TIR
domain or by interactions with other ROS-sensing proteins that
regulate Sarm1. Given the prominent role of calcium and ROS in
neurodegenerative disorders, the contribution of Sarm1 to neu-
rological disease is likely extensive, making sarmoptosis a poten-
tially promising target for therapeutic intervention.
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